[EN] 1,2,3,4-SUBSTITUTED QUINOLINE COMPOUNDS AS S1P MODULATORS [FR] COMPOSÉS DE QUINOLÉINE À SUBSTITUTION EN POSITIONS 1, 2, 3 ET 4 UTILISÉS EN TANT QUE MODULATEURS DE S1P
Diversifying Amino Acids and Peptides via Deaminative Reductive Cross-Couplings Leveraging High-Throughput Experimentation
作者:J. Cameron Twitty、Yun Hong、Bria Garcia、Stephanie Tsang、Jennie Liao、Danielle M. Schultz、Jennifer Hanisak、Susan L. Zultanski、Amelie Dion、Dipannita Kalyani、Mary P. Watson
DOI:10.1021/jacs.2c11451
日期:2023.3.15
A deaminative reductive coupling of amino acid pyridinium salts with aryl bromides has been developed to enable efficient synthesis of noncanonical amino acids and diversification of peptides. This method transforms natural, commercially available lysine, ornithine, diaminobutanoic acid, and diaminopropanoic acid to aryl alanines and homologated derivatives with varying chain lengths. Attractive features
1,2,3,4-SUBSTITUTED QUINOLINE COMPOUNDS AS S1P MODULATORS
申请人:Abbvie Deutschland GmbH & Co. KG
公开号:EP3655392A1
公开(公告)日:2020-05-27
1,2,3,4-SUBSTITUTED QUINOLINE COMPOUNDS AS SIP MODULATORS
申请人:AbbVie Deutschland GmbH & Co. KG
公开号:US20210147381A1
公开(公告)日:2021-05-20
The invention relates to 1,2,3,4-substituted quinoline compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.